Sanofi

Forecast & Rating10 analysts currently cover Sanofi, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $55.06, about 27.0% upside from the current price of $43.35. Price targets span a fair range, indicating some disagreement among institutions. For you, this means institutional views on Sanofi are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 25, 2026; for reference only and not investment advice.